Form 4 for ANIX Anixa Biosciences Inc
Accepted 2021-07-28 00:00:00 ET · period of report 2021-07-26 · accession 0001493152-21-017937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-28 | 2021-07-26 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $4.21 | +30.0K | 935.8K | +3% | +$126.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-26 | P | A | 30,000 | $4.21 | 935,826 | D | — | — |